The table below shows AMGEN INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$2.19B
$1.39B
$689.00M
$1.06B
$2.16B
$2.10B
Capital expenditure
$712.00M
$411.00M
$230.00M
$344.00M
$190.00M
$166.00M
Investing cash flow
-$716.00M
-$447.00M
-$217.00M
$1.36B
-$111.00M
-$319.00M
Dividends paid
$1.36B
$1.28B
$1.21B
$1.14B
AMGN operating cash flow (10-K history)
AMGEN INC reported operating cash flow of $9.96B for fiscal year 2025. That is down 13.3% from $11.49B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from $10.35B (FY 2016) to $9.96B. Figures come from the company's audited annual reports as filed with the SEC.
